Jean-Paul Alves

Jean-Paul Alves, BSc in Economy, Graduated from EM Lyon and Post Graduated in Managerial Accounting, Chartered Accounting and Tax, joined Pegascy in 2020 as Chief Financial Officer. He was appointed COO of Pegascy in 2021.

He began his career as Auditor at E&Y and Arthur Andersen. In 2000, he joined Lagardere Services as International Finance and M&A Advisor to the Executive Management. Later, he became Financial Director at AOL France (Time Warner) then Group CFO (and executive committee member) of Viadeo leading its IPO in 2014 before joining Biom’Up, a French Biotech, to organize its IPO in 2017 as Group CFO. Jean-Paul has a broad knowledge of international M&A and Funding operations with almost 10 acquisitions (including transactions in China, India, different countries in Europe, Russia and North America). He has carried out more than 20 funding operations during his career, including 2 IPO’s.

PEGASCY governance

Founders

MD, phD
 

Jean-harles Soria: is Amgen’s senior vice president of Oncology within Global Development. Soria joins Amgen from Institut Gustave Roussy

Jean-Charles

SORIA

Chief Executive Officer
 

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.

Jean-Pierre

ARMAND

MD, phD
 

Fabrice André: Director of Research at Gustave Roussy since February 2020, Prof. Fabrice André coordinates the Institute's medical-scientific research programs, in conjunction with the Medical Director.

Fabrice

ANDRÉ

 

MD, phD
 

Aurelie Marabelle: MD, PhD, is a Senior Medical Oncologist in the Drug Development Department (DITEP), a group leader in Prof Laurence Zitvogel’s lab (INSERM U1015)

Aurélien

MARABELLE

MBA
 

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London

Sébastien

BAZIN

MBA
 

Thierry Bruhat: he spent more than 20 years in supporting innovation projects and policies based on cooperation between companies, research

Thierry

BRUHAT

Board

Chairman
 

Jean-Pierre Armand MD, MSc, is certified in Medical Oncology (University of Toulouse III and Paris XI). He was recently General Director of the Institut Claudius Regaud in Toulouse.

Jean-Pierre

ARMAND

Censor
 

Sébastien Bazin: After five years working in several financial positions in New York, San Francisco and London

Sebastien

BAZIN

Directors
 

Fabrice Barlesi: As a specialist in lung cancer, precision medicine and cancer immunology

Fabrice

BARLESI

Directors
 

Olivier Edwards: is a lawyer who advises emerging companies and venture capital funds on investment, merger & acquisition matters with an emphasis on cross-border deals.

Olivier

EDWARDS

COO/CFO
 

Jean-Paul Alves, BSc in Economy, Graduated from EM Lyon and Post Graduated in Managerial Accounting, Chartered Accounting and Tax, joined Pegascy in 2020 as Chief Financial Officer.

Jean-Paul

ALVES